A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 12, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the QPRC SEC filings page.
This page shows QUEST PATENT RESEARCH CP (QPRC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Profit reversal revealed a business with heavy overhead, severe liquidity strain, and liabilities far exceeding assets.
FY2023 paired a$3.6M net profit with$1.9M of operating cash flow, so earnings were at least partly backed by cash. By FY2024, revenue had fallen to$2.8M while gross margin compressed to34.0% , leaving gross profit unable to absorb the cost base and producing an operating loss.
The balance sheet is not merely leveraged: FY2024 liabilities of
The reported liquidity comparison was only 0.4 months of FY2024 operating outflow, consistent with operating cash flow of
Financial Health Signals
QUEST PATENT RESEARCH CP does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
QUEST PATENT RESEARCH CP passes 3 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass.
For every $1 of reported earnings, QUEST PATENT RESEARCH CP used $2.96 of operating cash (-$5.9M OCF vs $2.0M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.
QUEST PATENT RESEARCH CP reported an operating loss of $7.7M against $700K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
QUEST PATENT RESEARCH CP generated $2.0M in revenue in Q2 2026.
QUEST PATENT RESEARCH CP reported -$2.1M in net income in Q2 2026. This represents a decrease of 85.8% from the same quarter a year earlier. Against the prior quarter it is up 27.9%.
QUEST PATENT RESEARCH CP earned -$0.40 per diluted share (EPS) in Q2 2026. This represents a decrease of 90.5% from the same quarter a year earlier. Against the prior quarter it is up 27.3%.
Not reported for Q2 2026.
Cash & Balance Sheet
QUEST PATENT RESEARCH CP held $481K in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Not reported for Q2 2026.
Margins & Returns
QUEST PATENT RESEARCH CP's gross margin was 100.0% in Q2 2026, indicating the percentage of revenue retained after direct costs.
QUEST PATENT RESEARCH CP's operating margin was -74.5% in Q2 2026, reflecting core business profitability.
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not reported for Q2 2026.
Capital Allocation
None of these metrics is reported for Q2 2026.
QPRC Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'24POS AM | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.0M | N/A | N/A | N/A | N/A | N/A | $0 | $900K+260.0% |
| Cost of Revenue | $0 | $1.7M | N/A | $0-100.0% | $0-100.0% | $0-100.0% | -$1K | $382K+582.1% |
| Gross Profit | $2.0M+41862.4% | -$1.7M-48817.9% | N/A | N/A | -$5K-101.0% | -$3K-100.7% | $1K | $248K+28.1% |
| SG&A Expenses | $1.1M+15.4% | $1.1M+70.9% | N/A | $1.0M+32.4% | $989K+21.1% | $654K+13.3% | $639K | $764K+27.7% |
| Operating Income | -$1.5M-49.9% | -$2.8M-329.9% | N/A | -$1.0M-96.1% | -$994K-181.4% | -$658K-601.0% | -$884K | -$516K+23.7% |
| Interest Expense | $186K+7.8% | $181K+7.4% | N/A | $178K+20.2% | $173K-24.8% | $168K+21.8% | -$397K | $148K-31.7% |
| Income Tax | $330K | N/A | N/A | N/A | N/A | N/A | N/A | -$5K |
| Net Income | -$2.1M-85.8% | -$2.9M-255.3% | N/A | -$1.2M-108.1% | -$1.1M-154.9% | -$826K-91.5% | -$1.0M | -$591K+29.0% |
| EPS (Basic) | -$0.40-90.5% | -$0.55-266.7% | -$0.99-450.0% | -$0.23-109.1% | -$0.21-162.5% | -$0.15-87.5% | -$0.18-118.4% | -$0.11+31.3% |
| EPS (Diluted) | -$0.40-90.5% | -$0.55-266.7% | -$0.99-450.0% | -$0.23-109.1% | -$0.21-162.5% | -$0.15-87.5% | -$0.18-118.4% | -$0.11+31.3% |
| Diluted Shares (Avg) | 5M0.0% | 5M0.0% | N/A | 5M0.0% | 5M0.0% | 5M0.0% | N/A | 5M0.0% |
Not reported in any period shown, so not listed: R&D Expenses, EBITDA.
QPRC Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'24POS AM | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $10.0M-14.3% | $10.3M+245.6% | $10.4M+194.8% | $11.0M+155.0% | $11.7M+170.3% | $3.0M-64.3% | $3.5M-51.4% | $4.3M-5.0% |
| Current Assets | $927K+232.7% | $655K+695.0% | $207K-58.7% | $194K-82.8% | $279K-71.5% | $82K-98.3% | $502K-86.1% | $1.1M+68.0% |
| Cash & Equivalents | $481K+88.7% | $620K+1196.2% | $193K-60.0% | $175K+28.0% | $255K+86.2% | $48K-93.8% | $482K-14.5% | $137K-77.6% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Receivable | $413K+4911.3% | $10K+16.3% | $8K0.0% | $8K-99.1% | $8K-98.9% | $8K | $8K-99.7% | $908K |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $32.3M+44.3% | $30.4M+143.3% | $27.6M+125.7% | $22.9M+90.6% | $22.4M+95.5% | $12.5M-16.7% | $12.2M-9.4% | $12.0M-24.9% |
| Current Liabilities | $32.1M+44.7% | $30.2M+145.7% | $27.4M+127.8% | $22.7M+92.2% | $22.1M+97.3% | $12.3M-16.9% | $12.0M-9.6% | $11.8M-25.3% |
| Non-Current Liabilities | $204K0.0% | $204K0.0% | $204K0.0% | $204K0.0% | $204K0.0% | $204K0.0% | $204K0.0% | $204K0.0% |
| Total Equity | -$22.2M-108.5% | -$20.1M-111.3% | -$17.2M-97.6% | -$11.9M-54.5% | -$10.7M-50.1% | -$9.5M-43.0% | -$8.7M-39.5% | -$7.7M+32.8% |
| Retained Earnings | -$39.9M-40.8% | -$37.8M-39.0% | -$34.9M-32.2% | -$29.6M-16.5% | -$28.3M-14.4% | -$27.2M-11.8% | -$26.4M-10.3% | -$25.4M+12.9% |
Not reported in any period shown, so not listed: Inventory, Goodwill, Long-Term Debt.
QPRC Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'24POS AM | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$1.6M-197.4% | -$2.2M-395.7% | -$4.4M-2773.6% | -$494K+1.2% | -$543K-160.8% | -$434K+30.9% | -$155K-104.5% | -$500K-19.5% |
| Capital Expenditures | N/A | N/A | N/A | $0 | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | -$494K | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | $0 | $0 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $1.5M | $2.6M | $4.5M+792.9% | $414K-17.1% | N/A | N/A | $500K+114.3% | $500K-46.3% |
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Dividends Paid, Share Buybacks.
QPRC Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'24POS AM | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 100.0% | N/A | N/A | N/A | N/A | N/A | N/A | 27.6%-50.0pp |
| Operating Margin | -74.5% | N/A | N/A | N/A | N/A | N/A | N/A | -57.3% |
| Net Margin | -105.9% | N/A | N/A | N/A | N/A | N/A | N/A | -65.7% |
| Return on Assets | -21.1%-11.4pp | -28.5%-0.8pp | N/A | -11.2%+2.5pp | -9.8%+0.6pp | -27.7%-22.5pp | -28.3% | -13.7%+4.7pp |
| Current Ratio | 0.030.0x | 0.020.0x | 0.010.0x | 0.01-0.1x | 0.01-0.1x | 0.01-0.3x | 0.04-0.2x | 0.10+0.1x |
| Asset Turnover | 0.20 | N/A | N/A | N/A | N/A | N/A | 0.00 | 0.21+0.2x |
Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity, FCF Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.
Note: Shareholder equity is negative (-$17.2M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.01), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| QUEST PATENT RESEARCH CP QPRC | FY2025 | N/A | $2.0M | N/A | $1.1M | — |
| CARO HOLDINGS INC CAHO | FY2026 | $11K | -$408K | N/A | $22.4M | — |
| ELVICTOR GROUP INC ELVG | FY2025 | $2.4M | -$176K | -7.2% | $5.3M | — |
Where QUEST PATENT RESEARCH CP Ranks
Frequently Asked Questions
Is QUEST PATENT RESEARCH CP profitable?
Yes, QUEST PATENT RESEARCH CP (QPRC) reported a net income of $2.0M in fiscal year 2025.
What is QUEST PATENT RESEARCH CP's operating cash flow?
QUEST PATENT RESEARCH CP (QPRC) recorded an outflow of $5.9M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are QUEST PATENT RESEARCH CP's total assets?
QUEST PATENT RESEARCH CP (QPRC) had $10.4M in total assets as of fiscal year 2025, including both current and long-term assets.
What is QUEST PATENT RESEARCH CP's current ratio?
QUEST PATENT RESEARCH CP (QPRC) had a current ratio of 0.01 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is QUEST PATENT RESEARCH CP's return on assets (ROA)?
QUEST PATENT RESEARCH CP (QPRC) had a return on assets of 19.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is QUEST PATENT RESEARCH CP's P/E ratio?
QUEST PATENT RESEARCH CP (QPRC) trades at 0.6x earnings, its market capitalization divided by net income of $2.0M net income, FY2025. The market capitalization is $1.1M as of Oct 12, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is QUEST PATENT RESEARCH CP's price-to-sales ratio?
QUEST PATENT RESEARCH CP (QPRC) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $1.1M as of Oct 12, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does QUEST PATENT RESEARCH CP's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, QUEST PATENT RESEARCH CP (QPRC) held $193K in cash, cash equivalents and investments, and reported an operating cash outflow of $5.9M over that year. Dividing the one by the other, the reported balance equals about 0 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Why is QUEST PATENT RESEARCH CP's debt-to-equity ratio negative or not reported?
QUEST PATENT RESEARCH CP (QPRC) has negative shareholder equity of -$17.2M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is QUEST PATENT RESEARCH CP's Piotroski F-Score?
QUEST PATENT RESEARCH CP (QPRC) has a Piotroski F-Score of 3 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are QUEST PATENT RESEARCH CP's earnings high quality?
For every $1 of reported earnings, QUEST PATENT RESEARCH CP (QPRC) used $2.96 of operating cash (-$5.9M OCF vs $2.0M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can QUEST PATENT RESEARCH CP cover its interest payments?
QUEST PATENT RESEARCH CP (QPRC) reported an operating loss of $7.7M against $700K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.